135 related articles for article (PubMed ID: 38706090)
21. Acute Promyelocytic Leukemia in Children: A Model of Precision Medicine and Chemotherapy-Free Therapy.
Gurnari C; Voso MT; Girardi K; Mastronuzzi A; Strocchio L
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33440683
[TBL] [Abstract][Full Text] [Related]
22. All-Trans Retinoic Acid-Induced Pseudotumor Cerebri during Induction Therapy for Acute Promyelocytic Leukemia: A Case Report and Literature Review.
Holmes D; Vishnu P; Dorer RK; Aboulafia DM
Case Rep Oncol Med; 2012; 2012():313057. PubMed ID: 22701192
[TBL] [Abstract][Full Text] [Related]
23. Effect of combination of all-trans retinoic acid and arsenic trioxide on apoptosis of acute promyelocytic leukemia cells.
Hu J; Sun Q; Fang W; Wang Q
Cell Mol Biol (Noisy-le-grand); 2019 Apr; 65(4):97-100. PubMed ID: 31078158
[TBL] [Abstract][Full Text] [Related]
24. Pseudotumor cerebri due to the potentiation of all-trans retinoic acid by voriconazole.
Dixon KS; Hassoun A
J Am Pharm Assoc (2003); 2010; 50(6):742-4. PubMed ID: 21071321
[TBL] [Abstract][Full Text] [Related]
25. Pseudotumor cerebri after treatment of relapsed acute promyelocytic leukemia with arsenic trioxide.
Galm O; Fabry U; Osieka R
Leukemia; 2000 Feb; 14(2):343-4. PubMed ID: 10673758
[No Abstract] [Full Text] [Related]
26. Incidence of secondary neoplasms in patients with acute promyelocytic leukemia treated with all-trans retinoic acid plus chemotherapy or with all-trans retinoic acid plus arsenic trioxide.
Eghtedar A; Rodriguez I; Kantarjian H; O'Brien S; Daver N; Garcia-Manero G; Ferrajoli A; Kadia T; Pierce S; Cortes J; Ravandi F
Leuk Lymphoma; 2015 May; 56(5):1342-5. PubMed ID: 25120050
[TBL] [Abstract][Full Text] [Related]
27. Retinoic acid syndrome induced by arsenic trioxide in treating recurrent all-trans retinoic acid resistant acute promyelocytic leukemia.
Che-Pin Lin ; Huang MJ; Chang IY; Lin WY; Sheu YT
Leuk Lymphoma; 2000 Jun; 38(1-2):195-8. PubMed ID: 10811463
[TBL] [Abstract][Full Text] [Related]
28. How retinoic acid and arsenic transformed acute promyelocytic leukemia therapy.
Korsos V; Miller WH
J Mol Endocrinol; 2022 Nov; 69(4):T69-T83. PubMed ID: 36112505
[TBL] [Abstract][Full Text] [Related]
29. Acute Promyelocytic Leukemia: Review of Complications Related to All-Trans Retinoic Acid and Arsenic Trioxide Therapy.
Ghiaur A; Doran C; Gaman MA; Ionescu B; Tatic A; Cirstea M; Stancioaica MC; Hirjan R; Coriu D
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539495
[TBL] [Abstract][Full Text] [Related]
30. Assessment of Arsenic Trioxide and All-trans Retinoic Acid for the Treatment of Pediatric Acute Promyelocytic Leukemia: A Report From the Children's Oncology Group AAML1331 Trial.
Kutny MA; Alonzo TA; Abla O; Rajpurkar M; Gerbing RB; Wang YC; Hirsch BA; Raimondi S; Kahwash S; Hardy KK; Hardy S; Meshinchi S; Gamis AS; Kolb EA; Feusner JH; Gregory J
JAMA Oncol; 2022 Jan; 8(1):79-87. PubMed ID: 34762093
[TBL] [Abstract][Full Text] [Related]
31. Optic Nerve Sheath Fenestration as Adjuvant Treatment for Severe Pseudotumor Cerebri Syndrome Induced by All-Trans Retinoic Acid.
Hokazono K; Cunha LP; Preti RC; Cabral Zacharias L; Ribeiro Monteiro ML
Case Rep Ophthalmol; 2023; 14(1):326-330. PubMed ID: 37485241
[TBL] [Abstract][Full Text] [Related]
32. Oral arsenic trioxide incorporation into frontline treatment with all-trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5-year prospective study.
Gill H; Kumana CR; Yim R; Hwang YY; Chan TSY; Yip SF; Lee HKK; Mak V; Lau JSM; Chan CC; Kho B; Wong RSM; Li W; Lin SY; Lau CK; Ip HW; Leung RYY; Lam CCK; Kwong YL
Cancer; 2019 Sep; 125(17):3001-3012. PubMed ID: 31090936
[TBL] [Abstract][Full Text] [Related]
33. 2-Bromopalmitate targets retinoic acid receptor alpha and overcomes all-trans retinoic acid resistance of acute promyelocytic leukemia.
Lu Y; Yan JS; Xia L; Qin K; Yin QQ; Xu HT; Gao MQ; Qu XN; Sun YT; Chen GQ
Haematologica; 2019 Jan; 104(1):102-112. PubMed ID: 30076181
[TBL] [Abstract][Full Text] [Related]
34. Relapsed acute promyelocytic leukemia in a hemodialysis-dependent patient treated with arsenic trioxide: a case report.
Emmons GS; Steingart RH; Stewart JA; Mertens WC
J Med Case Rep; 2012 Oct; 6():355. PubMed ID: 23078653
[TBL] [Abstract][Full Text] [Related]
35. Thrombocytosis in a patient with acute promyelocytic leukemia during treatment with all-
Habibi M; Manouchehri Ardekani R; Motedayyen H
Clin Case Rep; 2021 Apr; 9(4):2192-2195. PubMed ID: 33936662
[TBL] [Abstract][Full Text] [Related]
36. Have all-trans retinoic acid and arsenic trioxide replaced all-trans retinoic acid and anthracyclines in APL as standard of care.
Iland HJ; Wei A; Seymour JF
Best Pract Res Clin Haematol; 2014 Mar; 27(1):39-52. PubMed ID: 24907016
[TBL] [Abstract][Full Text] [Related]
37. Acute Myeloid Leukemia Acquiring Promyelocytic Leukemia-Retinoic Acid Receptor Alpha at Relapse.
Gupta V; Shariff M; Bajwa R; Patel I; Ayyad HA; Levitt MJ; Mencel PJ; Hossain MA
World J Oncol; 2019 Jun; 10(3):153-156. PubMed ID: 31312283
[TBL] [Abstract][Full Text] [Related]
38. Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial.
Iland HJ; Collins M; Bradstock K; Supple SG; Catalano A; Hertzberg M; Browett P; Grigg A; Firkin F; Campbell LJ; Hugman A; Reynolds J; Di Iulio J; Tiley C; Taylor K; Filshie R; Seldon M; Taper J; Szer J; Moore J; Bashford J; Seymour JF;
Lancet Haematol; 2015 Sep; 2(9):e357-66. PubMed ID: 26685769
[TBL] [Abstract][Full Text] [Related]
39. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.
Lo-Coco F; Avvisati G; Vignetti M; Thiede C; Orlando SM; Iacobelli S; Ferrara F; Fazi P; Cicconi L; Di Bona E; Specchia G; Sica S; Divona M; Levis A; Fiedler W; Cerqui E; Breccia M; Fioritoni G; Salih HR; Cazzola M; Melillo L; Carella AM; Brandts CH; Morra E; von Lilienfeld-Toal M; Hertenstein B; Wattad M; Lübbert M; Hänel M; Schmitz N; Link H; Kropp MG; Rambaldi A; La Nasa G; Luppi M; Ciceri F; Finizio O; Venditti A; Fabbiano F; Döhner K; Sauer M; Ganser A; Amadori S; Mandelli F; Döhner H; Ehninger G; Schlenk RF; Platzbecker U; ; ;
N Engl J Med; 2013 Jul; 369(2):111-21. PubMed ID: 23841729
[TBL] [Abstract][Full Text] [Related]
40. Severe Peripheral Neuropathy From Treatment With Arsenic Trioxide in a Patient Suffering From Acute Promyelocytic Leukemia.
Helso SN; Roug AS; Mork M; Maksten EF; Severinsen MT
J Hematol; 2020 Sep; 9(3):89-92. PubMed ID: 32855758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
